Answers are grounded in this paper and cite their sources.
Research demonstrates the effectiveness of assays to differentiate between synucleinopathy subtypes, suggesting future clinical applications.
α-Syn SAA holds the potential to become a routine assay for discriminating among synucleinopathy subtypes. Future research should focus on standardizing α-Syn SAA protocols, exploring the detailed mechanisms of distinct α-syn strains propagation, and developing novel therapeutic strategies based on these insights.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: